Tags

Type your tag names separated by a space and hit enter

Insulin pump therapy (continuous subcutaneous insulin infusion).
Prim Care. 2007 Dec; 34(4):845-71, vii.PC

Abstract

Continuous subcutaneous insulin infusion has provided patients who have diabetes with a system for achieving treatment targets with a lower incidence of severe hypoglycemia. Patients prefer the flexibility, convenience, and physiologic glycemic control of continuous subcutaneous insulin infusion. Future insulin pumps will be implanted within the body and the "loop" will be closed, providing a physiologic insulin delivery system. This system will provide the means for achieving near-normal glycemia, limit episodes of severe hypoglycemia, and prevent long-term complications of diabetes mellitus.

Authors+Show Affiliations

Department of Community and Family Medicine, University of Missouri-Kansas City School of Medicine, Truman Medical Center Lakewood, Kansas City, MO 64139, USA. Russell.White@tmcmed.org

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

18061820

Citation

White, Russell D.. "Insulin Pump Therapy (continuous Subcutaneous Insulin Infusion)." Primary Care, vol. 34, no. 4, 2007, pp. 845-71, vii.
White RD. Insulin pump therapy (continuous subcutaneous insulin infusion). Prim Care. 2007;34(4):845-71, vii.
White, R. D. (2007). Insulin pump therapy (continuous subcutaneous insulin infusion). Primary Care, 34(4), 845-71, vii.
White RD. Insulin Pump Therapy (continuous Subcutaneous Insulin Infusion). Prim Care. 2007;34(4):845-71, vii. PubMed PMID: 18061820.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Insulin pump therapy (continuous subcutaneous insulin infusion). A1 - White,Russell D, PY - 2007/12/7/pubmed PY - 2008/2/13/medline PY - 2007/12/7/entrez SP - 845-71, vii JF - Primary care JO - Prim Care VL - 34 IS - 4 N2 - Continuous subcutaneous insulin infusion has provided patients who have diabetes with a system for achieving treatment targets with a lower incidence of severe hypoglycemia. Patients prefer the flexibility, convenience, and physiologic glycemic control of continuous subcutaneous insulin infusion. Future insulin pumps will be implanted within the body and the "loop" will be closed, providing a physiologic insulin delivery system. This system will provide the means for achieving near-normal glycemia, limit episodes of severe hypoglycemia, and prevent long-term complications of diabetes mellitus. SN - 0095-4543 UR - https://www.unboundmedicine.com/medline/citation/18061820/Insulin_pump_therapy__continuous_subcutaneous_insulin_infusion__ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0095-4543(07)00065-6 DB - PRIME DP - Unbound Medicine ER -